Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Lenka Hovorková, Markéta Žaliová, Nicola C. Venn, Kirsten Bleckmann, Marie Trková, Eliška Potůčková, Martina Vašková, Jana Linhartová, Kateřina Machová Poláková, Eva Froňková,

Blood · 2017 · 134 citations · 44 references

DOIFull text

Open access

Concepts

Abstract

Key Points Combination of Ig/TCR and BCR-ABL1 genomic approach for MRD monitoring in childhood ALL reveals patients with CML-like disease. Monitoring ALL using BCR-ABL1 genomic breakpoint is feasible and enables the most specific and sensitive MRD quantification.

References

44